- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01023555
Increasing the Yield of Blood Cultures in Neonates
July 24, 2011 updated by: Shaare Zedek Medical Center
Increasing the Yield of Blood Cultures in the Neonatal Intensive Care Unit- A Prospective Controlled Trial
The purpose of this study is to determine whether the use of a single blood sample of 1cc in an aerobic bottle will provide a better yield and time to positivity than 2 samples of 0.5 cc in 2 (aerobic and anaerobic) bottles for blood cultures in neonates.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
1500
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- All blood cultures taken in the NICU during the study period.
Exclusion Criteria:
- Bacteria that are normal flora of the skin such as Coagulase negative staphylococci or Streptococci Viridans are considered, except if grown in two sets of cultures or in the presence of laboratory and clinical indices of infection.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: 0.5cc 2 Bottles
|
|
|
Active Comparator: 1cc single bottle
|
The efficacy of using 1cc of blood in a single aerobic bottle for cultures in neonatal bacteremia will will be compared with the traditional 0.5cc of blood in 2 Bottles
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Non Inferiority of 1 cc blood culture in a single aerobic bottle instead of 0.5 cc for 2 bottles.
Time Frame: 6months
|
6months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
utility of the routine use of anaerobic bottle for blood cultures in newborns
Time Frame: 6 months
|
6 months
|
|
Comparison of time to positivity of 1 cc blood culture in a single aerobic bottle instead of 0.5 cc for 2 bottles (aerobic and anaerobic)
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2010
Primary Completion (Actual)
July 1, 2010
Study Completion (Actual)
July 1, 2010
Study Registration Dates
First Submitted
December 1, 2009
First Submitted That Met QC Criteria
December 1, 2009
First Posted (Estimate)
December 2, 2009
Study Record Updates
Last Update Posted (Estimate)
July 26, 2011
Last Update Submitted That Met QC Criteria
July 24, 2011
Last Verified
July 1, 2011
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SZMC-bromi
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bacteremia
-
University Hospital, Strasbourg, FranceRecruiting
-
West Virginia UniversityEnrolling by invitationStaphylococcus Aureus BacteremiaUnited States
-
Armata Pharmaceuticals, Inc.United States Department of DefenseCompletedBacteremia | Staphylococcus Aureus | Staphylococcus Aureus Bacteremia | Bacteremia Due to Staphylococcus Aureus | Bacteremia StaphUnited States, Australia
-
Osijek University HospitalCompletedSepsis | Gram-negative Bacteremia | Gram-Positive BacteremiaCroatia
-
Intermountain Health Care, Inc.Not yet recruitingStaphylococcus Aureus BacteremiaUnited States
-
Rabin Medical CenterCompletedGram Negative BacteremiaIsrael, Italy
-
Duke UniversityMerck Sharp & Dohme LLCCompletedBacteremia | Gram-negative BacteremiaUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingGram-negative Bacteremia | Intensive Care Patients
-
Singapore General HospitalSingapore Clinical Research InstituteTerminatedBacteremia Due to Staphylococcus AureusSingapore
-
The First Affiliated Hospital of Xinxiang Medical...RecruitingSalmonella BacteremiaChina
Clinical Trials on 1cc of blood in a single aerobic culture bottle
-
University Hospital MuensterPfizer; Hoffmann-La RocheCompletedSepsis | Hematologic Diseases | Neutropenia | Febrile NeutropeniaGermany
-
Assistance Publique - Hôpitaux de ParisHoffmann-La RocheCompletedFebrile Neutropenia | Severe Sepsis | EndocarditisFrance
-
University of UlmRecruitingCOVID-19 | Critical Illness | Lung Fibrosis | HypercytokinemiaGermany
-
Memorial Sloan Kettering Cancer CenterUniversity of Pisa; University of California, San Francisco; The Champalimaud...Active, not recruitingMelanoma | Sarcoma | Ovarian Cancer | Bone | Soft Tissue | Lymph Nodes | CNS-Spinal CD/MEMBR, NOSUnited States, Italy, Portugal
-
Fondazione Policlinico Universitario Agostino Gemelli...Recruiting
-
Hospices Civils de LyonBioMérieuxRecruiting
-
Assistance Publique Hopitaux De MarseilleUnknown
-
University of PennsylvaniaEli Lilly and CompanyActive, not recruitingHealthyUnited States
-
Imperial College LondonDexCom, Inc.; Bold insightRecruitingPregnancy Complications | Gestational DiabetesUnited Kingdom
-
University Hospital, BordeauxRecruiting